Advancing head and neck cancer following the coronavirus disease 2019 pandemic DOI
William Flynn,

R Maqsood,

T. Maseland

et al.

The Journal of Laryngology & Otology, Journal Year: 2022, Volume and Issue: 136(11), P. 1118 - 1124

Published: April 21, 2022

Delay in the diagnosis of head and neck cancer can result significant excess morbidity mortality. How pandemic has affected patient presentation Scotland is unknown.This retrospective cohort study compared all presentations between June October 2019 with same period following peak 2020 West Scotland, a region populated by 2.5 million people.A total 528 patients met our inclusion criteria. Compared 2019, were more likely to present higher American Joint Committee on Cancer stage (odds ratio, 1.67 (95 per cent confidence interval = 1.20 2.31); p 0.002), longer preceding symptom duration 2.03 1.44 2.87; < 0.001) have an emergency 2.53, 1.15 5.55; 0.017).Patients are presenting later advanced coronavirus disease pandemic.

Language: Английский

Análisis de la supervivencia de los pacientes con tumores malignos de cabeza y cuello diagnosticados durante la pandemia de COVID-19 DOI
Xavier León, Cristina Valero, Anna Holgado

et al.

Acta Otorrinolaringológica Española, Journal Year: 2025, Volume and Issue: 76(2), P. 106 - 115

Published: Feb. 16, 2025

Citations

0

Prioritization of head and neck cancer patient care during the COVID-19 pandemic: A retrospective cohort study DOI Creative Commons

Samuel S. Psycharis,

Samer Salameh, Sena Turkdogan

et al.

Journal of Otolaryngology - Head and Neck Surgery, Journal Year: 2023, Volume and Issue: 52(1)

Published: Jan. 1, 2023

The COVID-19 pandemic placed considerable strain on the healthcare system, leading to re-allocation of resources and implementation new practice guidelines. objective this study is assess impact guideline modifications head neck cancer (HNC) care at two tertiary centers in Canada.A retrospective cohort was conducted. HNC patients seen before after onset (pre-pandemic: July 1st, 2019, February 29th, 2020; pandemic: March 2020, October 31st, 2020) were included. pre-pandemic cohorts compared according patient tumor characteristics, duration workup, treatment type duration. Mean differences wait times, including time diagnosis, board, as well total package postoperative hospital stay between cohorts. Univariate multivariate analyses used compare characteristics outcomes cohorts.Pre-pandemic (n = 132) 133) did not differ significantly sex, age, habits, or characteristics. percentage who received surgery only, chemo/radiotherapy (CXRT) plus adjuvant CXRT Pandemic experienced a significant reduction with regards date first by service until start ([Formula: see text] 48.7 76.6 days respectively; p .0001), presentation board 25.1 38 .001), mean for only 3.7 9.0 .017), 80.2 112.7 .035).The reduced during pre-pandemic. This transparent model patient-centered operative-room prioritization can serve improving resource allocation efficiency emergency non-emergency scenarios.

Language: Английский

Citations

10

The effect of the COVID-19 pandemic on the diagnosis and progression of oral cancer DOI Creative Commons
Michelle Cwintal, Hsin‐I Shih,

A. Idrissi Janati

et al.

International Journal of Oral and Maxillofacial Surgery, Journal Year: 2024, Volume and Issue: 53(8), P. 629 - 634

Published: Feb. 22, 2024

The COVID-19 pandemic placed a significant burden on healthcare resources, limiting care to emergent and essential services only. objective of this study was describe the effect diagnosis progression oral cancer lesions in Montreal, Canada. A retrospective analysis health records performed. Patients presenting for new oncology consultation an lesion suspicious between March 2018 2022, within Department Oral Maxillofacial Surgery McGill University Health Center, were included. Data collected sociodemographic characteristics, risk behaviors participants, delays, tumor clinical management. total 190 patients included, 91 from pre-pandemic period 99 period. demographic characteristics two periods comparable. There no difference patient, professional, or treatment delay periods. non-significant increase pathologic size during pandemic, but staging postoperative outcomes comparable those cohort. results indicate that pathways efficiently maintained despite shutdown services.

Language: Английский

Citations

3

Impact of the COVID-19 Pandemic on the Treatment of Head and Neck Cancers DOI Open Access
Max Lee, Andrey Finegersh, Michelle Chen

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(5), P. 1424 - 1424

Published: Feb. 20, 2025

Background/Objectives: The COVID-19 pandemic led to unprecedented disruptions cancer care, including the care of head and neck cancer. Given necessity timely treatment for mucosal cancers, it is important understand how affected diagnosis, presentation, Methods: National Cancer Database was queried patients with primary number annual diagnoses days between diagnosis start end any were tracked over time from 2004 2020. Chi-square tests used compare differences in patient clinical demographic characteristics 2019 2020 provide most direct comparison. Multivariable linear regression logic analyses also three quality measures 2020: treatment, surgery postoperative radiation, radiation. Results: decreased (9.1%) during early stages pandemic, a larger decrease (12.4%) among receiving surgery. On multivariable analysis comparing 2019, shorter (2.3 days; 95% CI, 1.69 2.85 days), radiation less likely be delayed (OR, 0.91 greater than 42 surgery; 0.85 0.97). However, who black, female, older, or uninsured more experience delays. Conclusions: Overall, there no delays surgical pandemic. vulnerable groups, such as uninsured, at higher risk experiencing

Language: Английский

Citations

0

Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends DOI Creative Commons
Hanna M. Peacock, Cindy De Gendt, Geert Silversmit

et al.

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: Sept. 20, 2023

During the first wave of COVID-19 pandemic in 2020, non-essential health services were suspended Belgium, and public was ordered to socially isolate. Underdiagnosis cancer during this period reported worldwide. Certain risk factors for head neck (HNC) overlap with those incidence mortality, making underdiagnosis subsequent stage shift potentially rapidly progressing a major concern. We aimed analyze incidence, clinical at presentation, survival patients diagnosed HNC 2020 considering recent temporal trends.Using population-based data from Belgian Cancer Registry (BCR), we extrapolated 2017-2019 trends stage, 1-year relative (1yRS) create an expected value compared observed value.There 9.5% fewer HNCs predicted incidence. larger males (-11.8%), aged 50-64 (-11.2%) 65-79 (-11.1%), oral cavity (-17.6%). Shifts more advanced stages larynx oropharynx tumors (male) 80+. A 2.4 percentage point decline 1yRS observed, increasing (2017-2019).The led HNC, resulting shifts presentation certain subgroups. can be not yet end 2020. suffered higher than mortality.

Language: Английский

Citations

9

Head and Neck Cancer During Covid-19 Pandemic: Was there a Diagnostic Delay? DOI Open Access
Daniela Lucidi,

Sara Valerini,

Gaia Federici

et al.

Indian Journal of Otolaryngology and Head & Neck Surgery, Journal Year: 2022, Volume and Issue: 74(S2), P. 3245 - 3251

Published: Jan. 15, 2022

Language: Английский

Citations

14

The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis DOI Open Access

Yashi Ballal,

Maru Gete,

Jie Su

et al.

Oral Oncology, Journal Year: 2023, Volume and Issue: 138, P. 106332 - 106332

Published: Feb. 3, 2023

Language: Английский

Citations

7

Head and neck oncology management in the time of COVID-19: results of a head and neck cancer center DOI Creative Commons

S. Heckel,

Christopher Bohr, Johannes K. Meier

et al.

Journal of Cancer Research and Clinical Oncology, Journal Year: 2023, Volume and Issue: 149(13), P. 12081 - 12087

Published: July 8, 2023

Abstract Purpose Given the concerns about effects of COVID-19 pandemic on cancer care, we analyzed treatment quality head and neck center Regensburg before throughout 2 years pandemic. We included data 3 to reflect extended period as new developments continued influence its course. Methods This retrospective review all patients diagnosed with in 2019, 2020, 2021 who had not started elsewhere prior being referred center. compared tumor characteristics times therapy 2019 (n = 253), during 2020 206), a phase partial normalization persistent situation 247). Results Our revealed no decrease diagnoses or drift stages toward more advanced stages. There was an increased percentage confirmed at from (57.3%) (68.0%) (65.6%) confirmation other institutions (2019, 42.7%; 32.0%; 2021, 34.4%; P 0.041). Surgery radiotherapy were performed same frequency. The median days between diagnosis surgery decreased (19.5 days; 0.049) (20.0 0.026) comparison (23 days). affected. Conclusion indicate consistent oncological performance for waves thereafter without shift

Language: Английский

Citations

7

Impact of the Sars-COVID-19 Pandemic on the “Early Diagnosis” of Laryngeal Tumors: Data From Monocentric Tertiary Care Hospital of South Italy DOI
Cosimo Galletti,

Laura De Marco,

Francesco Ciodaro

et al.

Journal of Voice, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

Language: Английский

Citations

2

In silico analysis of the key molecules of SARS-CoV-2: ACE2 and TMPRSS2 in head and neck cancer DOI
Vignesh Mariappan, Aashika Raagavi JeanPierre,

P. S. Manoharan

et al.

Human Gene, Journal Year: 2024, Volume and Issue: 40, P. 201282 - 201282

Published: March 30, 2024

Language: Английский

Citations

2